Expertise in
2
conditions

Gunhild Von Amsberg

Hamburg, HH, DE 
Expertise in
2
conditions
Hamburg, HH, DE 
OverviewLocationsClinical Research

Overview

Gunhild Von Amsberg practices in Hamburg, Germany. Ms. Von Amsberg is highly rated in 2 conditions, according to our data. Her top areas of expertise are Prostate Cancer, Urothelial Cancer, Testicular Cancer, Bone Marrow Transplant, and Prostatectomy.

Her clinical research consists of co-authoring 103 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Female

Locations

Hamburg, HH, Germany
Other Locations
Eppendorf, HH, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

CYCLONE 3: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abemaciclib in Combination With Abiraterone Plus Prednisone in Men With High-Risk Metastatic Hormone-Sensitive Prostate Cancer
CYCLONE 3: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abemaciclib in Combination With Abiraterone Plus Prednisone in Men With High-Risk Metastatic Hormone-Sensitive Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: June 27, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Multicenter, Open-label, Dose-escalating, Phase I Trial With GEM3PSCA, a PSCA Targeted Bispecific Antibody Engaging T-cells, in Patients With Progressive Disease After Standard Systemic Therapy in Cancers With Positive PSCA Marker
A Multicenter, Open-label, Dose-escalating, Phase I Trial With GEM3PSCA, a PSCA Targeted Bispecific Antibody Engaging T-cells, in Patients With Progressive Disease After Standard Systemic Therapy in Cancers With Positive PSCA Marker
Enrollment Status: Terminated
Publish Date: July 10, 2023
Intervention Type: Drug
Study Drug: GEM3PSCA
Study Phase: Phase 1
View 1 Less Clinical Trial

103 Total Publications

Therapy Management of PARP Inhibitor Combinations in mCRPC Clinical Practice
Therapy Management of PARP Inhibitor Combinations in mCRPC Clinical Practice
Journal: Aktuelle Urologie
Published: October 27, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Von Amsberg's expertise for a condition
ConditionClose
    View All 12 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile